Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.01 USD | -8.82% | -8.87% | +32.40% |
08/05 | Addex to Present at BioEURquity Europe 2024 | DJ |
30/04 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
Business Summary
Number of employees: 23
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small-molecule Pharmaceutical Products
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +13.99% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +13.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01/02/01 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 01/17/01 |
Vincent Lawton
CHM | Chairman | 75 | 16/09/16 |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 28/16/28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 53 | 01/18/01 |
Tim Dyer
FOU | Founder | 56 | 01/02/01 |
Vincent Lawton
CHM | Chairman | 75 | 16/09/16 |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 28/16/28 |
Isaac Manke
BRD | Director/Board Member | 47 | 01/18/01 |
Ray Hill
BRD | Director/Board Member | 79 | 01/08/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 181,952,457 | 87,566,943 ( 48.13 %) | 59,159,103 ( 32.51 %) | 48.13 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ADDEX THERAPEUTICS LTD 23.93% | 44,113,438 | 23.93% | 2,933,985 $ |
Company contact information
Addex Therapeutics Ltd.
9, Chemin des Mines Plan-les-Ouates
1202, Geneva
+41 22 884 1555
http://www.addextherapeutics.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ADXN Stock
- ADXN Stock
- Company Addex Therapeutics Ltd